NeuroVision Imaging
PrivateLast Round
Grant
Aug 24, 2021
Total Funding Raised
$27.74M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuroVision Imaging operates in Healthcare & Life Sciences and is based in Sacramento, California. Its latest recorded funding round was a Grant round in August 2021.
NeuroVision Imaging is a medical technology company that provides a telehealth platform and develops diagnostic tests and retinal imaging technology for the early detection and monitoring of Alzheimer's Disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Telemedicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroVision Imaging Comparables
Compare NeuroVision Imaging with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RetiSpec | 81% | |
| Cognoptix | 78% | |
| Head Diagnostics | 77% |
For institutional investors. Book with your work email.
NeuroVision Imaging Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 24, 2021 | ||||
| Grant | Feb 1, 2021 | ||||
| Series C | May 2, 2018 | ||||
| Series B | Jun 29, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroVision Imaging Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wildcat Capital Management | Series B, Series C |
| SBI Investment Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jul 29, 2026
Grew 17% QoQ, from 18 to 21 employees.
For institutional investors. Book with your work email.
NeuroVision Imaging Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroVision Imaging's valuation, stock price, and market status.
Is NeuroVision Imaging a public or private company?
NeuroVision Imaging is a private company.
What is the current stock price of NeuroVision Imaging?
NeuroVision Imaging is a private company, so its shares have no public market price. Caplight tracks NeuroVision Imaging's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroVision Imaging worth (valuation)?
Valuation information for NeuroVision Imaging is not publicly available.
Can I buy NeuroVision Imaging stock?
NeuroVision Imaging shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroVision Imaging's last funding round?
NeuroVision Imaging's most recent funding round was Grant on August 24, 2021.
Who are the main investors in NeuroVision Imaging?
Key investors in NeuroVision Imaging include Wildcat Capital Management.
Will NeuroVision Imaging IPO soon?
No public IPO plans have been announced for NeuroVision Imaging.
How can I track NeuroVision Imaging secondary market activity?
Caplight tracks bids, offers, and trades in NeuroVision Imaging's shares on secondary markets.